Q4 2024 · 13F-HR
TANG CAPITAL MANAGEMENT LLCholdings as filed
Filed 2025-02-14 · accession 0001214659-25-002812
$1.51B
Reported value
183
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $124.8M | 8.26% | 2,254,797 | Common | SHARED |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $75.7M | 5.01% | 8,429,500 | Common | SHARED |
| 36315X101 | LKFT | GALAPAGOS NV | $59.4M | 3.93% | 2,161,200 | Common | SHARED |
| 30052C107 | EOLS | EVOLUS INC | $55.2M | 3.65% | 4,997,399 | Common | SHARED |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $51.2M | 3.38% | 1,237,107 | Common | SHARED |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $47.8M | 3.16% | 2,492,925 | Common | SHARED |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $45.9M | 3.04% | 1,555,600 | Common | SHARED |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $41.5M | 2.74% | 4,893,847 | Common | SHARED |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $33.2M | 2.20% | 8,068,058 | Common | SHARED |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $32.7M | 2.16% | 2,700,000 | Common | SHARED |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $31.6M | 2.09% | 700,000 | Common | SHARED |
| 09075V102 | BNTX | BIONTECH SE | $30.8M | 2.04% | 270,000 | Common | SHARED |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $27.5M | 1.82% | 1,500,000 | Common | SHARED |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $25.1M | 1.66% | 300,000 | Common | SHARED |
| 92243G108 | PCVX | VAXCYTE INC | $24.6M | 1.62% | 300,000 | Common | SHARED |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $23.6M | 1.56% | 1,850,000 | Common | SHARED |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $22.1M | 1.47% | 766,940 | Common | SHARED |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $20.5M | 1.35% | 150,000 | Common | SHARED |
| 02155H200 | ALT | ALTIMMUNE INC | $19.8M | 1.31% | 2,750,000 | Common | SHARED |
| 67066G104 | NVDA | NVIDIA CORPORATION | $19.1M | 1.27% | 142,569 | Common | SHARED |
| 032724106 | ANAB | ANAPTYSBIO INC | $17.6M | 1.17% | 1,330,879 | Common | SHARED |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $17.6M | 1.16% | 317,500 | Common | SHARED |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $17.2M | 1.14% | 140,000 | Common | SHARED |
| 98985Y108 | ZYME | ZYMEWORKS INC | $16.1M | 1.07% | 1,100,000 | Common | SHARED |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $16.0M | 1.06% | 4,788,912 | Common | SHARED |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $15.7M | 1.04% | 1,497,500 | Common | SHARED |
| 30303M102 | META | META PLATFORMS INC | $15.6M | 1.03% | 26,600 | Common | SHARED |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $14.6M | 0.97% | 450,000 | Common | SHARED |
| 37733W204 | GSK | GSK PLC | $13.5M | 0.90% | 400,000 | Common | SHARED |
| 80105N105 | SNY | SANOFI | $13.0M | 0.86% | 270,000 | Common | SHARED |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $12.9M | 0.86% | 1,100,000 | Common | SHARED |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $12.9M | 0.85% | 320,000 | Common | SHARED |
| 87918A105 | TDOC | TELADOC HEALTH INC | $12.7M | 0.84% | 1,400,000 | Common | SHARED |
| 60770K107 | MRNA | MODERNA INC | $12.5M | 0.83% | 300,000 | Common | SHARED |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $12.4M | 0.82% | 628,609 | Common | SHARED |
| 23256X407 | HELP | CYBIN INC | $11.7M | 0.78% | 1,330,097 | Common | SHARED |
| 921659108 | VNDA | VANDA PHARMACEUTICALS INC | $11.3M | 0.75% | 2,353,307 | Common | SHARED |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $11.2M | 0.74% | 921,138 | Common | SHARED |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $10.5M | 0.69% | 266,500 | Common | SHARED |
| 67080N101 | NUVB | NUVATION BIO INC | $10.4M | 0.69% | 3,900,000 | Common | SHARED |
| 43157M102 | — | HILLEVAX INC | $10.2M | 0.67% | 4,920,000 | Common | SHARED |
| 046353108 | AZNN | ASTRAZENECA PLC | $9.8M | 0.65% | 150,000 | Common | SHARED |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $9.7M | 0.64% | 800,000 | Common | SHARED |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $9.7M | 0.64% | 281,200 | Common | SHARED |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $9.4M | 0.62% | 550,000 | Common | SHARED |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $9.4M | 0.62% | 750,000 | Common | SHARED |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $9.2M | 0.61% | 640,000 | Common | SHARED |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $9.1M | 0.60% | 1,480,975 | Common | SHARED |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $8.6M | 0.57% | 5,900,000 | Common | SHARED |
| 071705107 | BLCO | BAUSCH PLUS LOMB CORP | $8.1M | 0.54% | 450,000 | Common | SHARED |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC COM | $8.0M | 0.53% | 300,000 | Common | SHARED |
| 007002108 | TORCEUR | ADICET BIO INC | $7.8M | 0.52% | 8,145,988 | Common | SHARED |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $7.7M | 0.51% | 4,300,000 | Common | SHARED |
| 09077V100 | BIOA | BIOAGE LABS INC | $7.6M | 0.51% | 1,318,361 | Common | SHARED |
| 00288U106 | ABCL | ABCELLERA BIOLOGICS INC | $7.6M | 0.50% | 2,582,816 | Common | SHARED |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $7.5M | 0.50% | 7,311,760 | Common | SHARED |
| 82933R308 | — | SINGULAR GENOMICS SYSTEMS IN | $7.2M | 0.48% | 372,000 | Common | SHARED |
| 45256X103 | IBRX | IMMUNITYBIO INC | $7.2M | 0.48% | 2,814,192 | Common | SHARED |
| 457669307 | INSM | INSMED INC | $6.9M | 0.46% | 100,000 | Common | SHARED |
| 07725L102 | ONC | BEIGENE LTD | $6.8M | 0.45% | 37,000 | Common | SHARED |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $6.8M | 0.45% | 3,100,000 | Common | SHARED |
| 48115J109 | DERM | JOURNEY MED CORP | $6.7M | 0.45% | 1,725,569 | Common | SHARED |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $6.0M | 0.40% | 800,000 | Common | SHARED |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $5.8M | 0.38% | 264,692 | Common | SHARED |
| 65487U108 | NKTX | NKARTA INC | $5.7M | 0.38% | 2,293,719 | Common | SHARED |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $5.5M | 0.36% | 3,296,883 | Common | SHARED |
| 09062X103 | BIIB | BIOGEN INC | $5.4M | 0.35% | 35,000 | Common | SHARED |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $5.2M | 0.35% | 150,000 | Common | SHARED |
| G1110E107 | BHVN | BIOHAVEN LTD | $5.2M | 0.35% | 140,000 | Common | SHARED |
| 81578P106 | SEER | SEER INC | $5.1M | 0.34% | 2,194,423 | Common | SHARED |
| 19249H103 | CHRS | COHERUS BIOSCIENCES INC | $5.0M | 0.33% | 3,650,000 | Common | SHARED |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $4.8M | 0.32% | 720,000 | Common | SHARED |
| 670002401 | NVAX | NOVAVAX INC | $4.8M | 0.32% | 600,000 | Common | SHARED |
| 022307102 | ALMS | ALUMIS INC | $4.7M | 0.31% | 600,000 | Common | SHARED |
| 23282W605 | CYTK | CYTOKINETICS INC | $4.7M | 0.31% | 100,000 | Common | SHARED |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $4.5M | 0.30% | 100,000 | Common | SHARED |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $4.5M | 0.30% | 50,000 | Common | SHARED |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $4.4M | 0.29% | 2,070,209 | Common | SHARED |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $4.4M | 0.29% | 100,000 | Common | SHARED |
| N5749R100 | 2GH | MERUS N V | $4.2M | 0.28% | 100,000 | Common | SHARED |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $4.1M | 0.27% | 500,000 | Common | SHARED |
| 670703107 | NUVL | NUVALENT INC | $3.9M | 0.26% | 50,000 | Common | SHARED |
| 015271109 | ARE | ALEXANDRIA REAL ESTATE EQ IN | $3.9M | 0.26% | 40,000 | Common | SHARED |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $3.8M | 0.25% | 1,000,000 | Common | SHARED |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $3.7M | 0.24% | 500,000 | Common | SHARED |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $3.7M | 0.24% | 79,166 | Common | SHARED |
| 384747101 | GRAL | GRAIL INC | $3.6M | 0.24% | 200,000 | Common | SHARED |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $3.3M | 0.22% | 300,000 | Common | SHARED |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $3.3M | 0.22% | 2,140,271 | Common | SHARED |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $3.2M | 0.21% | 900,000 | Common | SHARED |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $3.1M | 0.20% | 1,855,954 | Common | SHARED |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $3.0M | 0.20% | 100,000 | Common | SHARED |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $2.9M | 0.19% | 242,653 | Common | SHARED |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $2.7M | 0.18% | 74,265 | Common | SHARED |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $2.7M | 0.18% | 4,760,000 | Common | SHARED |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $2.7M | 0.18% | 50,000 | Common | SHARED |
| 74019P207 | DTIL | PRECISION BIOSCIENCES INC | $2.6M | 0.17% | 673,332 | Common | SHARED |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $2.5M | 0.17% | 294,626 | Common | SHARED |
| G8807B106 | TBPH | THERAVANCE BIOPHARMA INC | $2.5M | 0.16% | 262,896 | Common | SHARED |
| 002120202 | ATYR | ATYR PHARMA INC | $2.4M | 0.16% | 671,134 | Common | SHARED |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $2.2M | 0.15% | 50,000 | Common | SHARED |
| 14167L103 | CDNA | CAREDX INC | $2.1M | 0.14% | 100,000 | Common | SHARED |
| 372303206 | GMAB | GENMAB A/S | $2.1M | 0.14% | 100,000 | Common | SHARED |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $2.1M | 0.14% | 2,428,169 | Common | SHARED |
| 45168D104 | IDXX | IDEXX LABS INC | $2.1M | 0.14% | 5,000 | Common | SHARED |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $2.0M | 0.13% | 3,812,773 | Common | SHARED |
| 34965K107 | FTRE | FORTREA HLDGS INC | $1.9M | 0.12% | 100,000 | Common | SHARED |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $1.7M | 0.11% | 221,716 | Common | SHARED |
| 46625H100 | JPM | JPMORGAN CHASE & CO. | $1.6M | 0.10% | 6,601 | Common | SHARED |
| 931142103 | WMT | WALMART INC | $1.6M | 0.10% | 17,423 | Common | SHARED |
| 88427A107 | — | THIRD HARMONIC BIO INC | $1.5M | 0.10% | 150,000 | Common | SHARED |
| 29479A108 | ERAS | ERASCA INC | $1.5M | 0.10% | 602,915 | Common | SHARED |
| 92826C839 | V | VISA INC | $1.5M | 0.10% | 4,718 | Common | SHARED |
| 254687106 | DIS | DISNEY WALT CO | $1.5M | 0.10% | 13,095 | Common | SHARED |
| 594918104 | MSFT | MICROSOFT CORP | $1.4M | 0.10% | 3,413 | Common | SHARED |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $1.4M | 0.09% | 2,000 | Common | SHARED |
| 92556V106 | VTRS | VIATRIS INC | $1.4M | 0.09% | 114,316 | Common | SHARED |
| 084670702 | BRK/B | BERKSHIRE HATHAWAY INC DEL | $1.4M | 0.09% | 3,099 | Common | SHARED |
| 92337C203 | VSTM | VERASTEM INC | $1.4M | 0.09% | 270,000 | Common | SHARED |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $1.4M | 0.09% | 200,000 | Common | SHARED |
| 70450Y103 | PYPL | PAYPAL HLDGS INC | $1.3M | 0.09% | 15,714 | Common | SHARED |
| 742718109 | PG | PROCTER AND GAMBLE CO | $1.3M | 0.09% | 7,962 | Common | SHARED |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $1.3M | 0.09% | 100,000 | Common | SHARED |
| 437076102 | HD | HOME DEPOT INC | $1.3M | 0.09% | 3,353 | Common | SHARED |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $1.2M | 0.08% | 50,000 | Common | SHARED |
| 92343V104 | VZ | VERIZON COMMUNICATIONS INC | $1.2M | 0.08% | 30,877 | Common | SHARED |
| 882508104 | TXN | TEXAS INSTRS INC | $1.2M | 0.08% | 6,568 | Common | SHARED |
| 191216100 | KO | COCA COLA CO | $1.2M | 0.08% | 19,714 | Common | SHARED |
| 910047109 | UAL | UNITED AIRLS HLDGS INC | $1.2M | 0.08% | 12,392 | Common | SHARED |
| 64110L106 | NFLX | NETFLIX INC | $1.2M | 0.08% | 1,344 | Common | SHARED |
| 654106103 | NKE | NIKE INC | $1.2M | 0.08% | 15,789 | Common | SHARED |
| 30231G102 | XOM | EXXON MOBIL CORP | $1.2M | 0.08% | 11,053 | Common | SHARED |
| 90384S303 | ULTA | ULTA BEAUTY INC | $1.2M | 0.08% | 2,699 | Common | SHARED |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $1.2M | 0.08% | 2,308 | Common | SHARED |
| 478160104 | JNJ | JOHNSON & JOHNSON | $1.2M | 0.08% | 7,959 | Common | SHARED |
| 717081103 | PFE | PFIZER INC | $1.1M | 0.08% | 42,908 | Common | SHARED |
| 025816109 | AXP | AMERICAN EXPRESS CO | $1.1M | 0.07% | 3,799 | Common | SHARED |
| 458140100 | INTC | INTEL CORP | $1.1M | 0.07% | 55,997 | Common | SHARED |
| 097023105 | BA | BOEING CO | $1.1M | 0.07% | 6,294 | Common | SHARED |
| 023135106 | AMZN | AMAZON COM INC | $1.1M | 0.07% | 5,071 | Common | SHARED |
| 68401U204 | OPRX | OPTIMIZERX CORP | $1.1M | 0.07% | 221,200 | Common | SHARED |
| 68218J103 | OABI | OMNIAB INC | $1.1M | 0.07% | 300,000 | Common | SHARED |
| 020002101 | ALL | ALLSTATE CORP | $1.0M | 0.07% | 5,319 | Common | SHARED |
| 046513206 | ATRA | ATARA BIOTHERAPEUTICS INC | $1.0M | 0.07% | 75,196 | Common | SHARED |
| 440452100 | HRL | HORMEL FOODS CORP | $995,706 | 0.07% | 31,741 | Common | SHARED |
| 872590104 | TMUS | T-MOBILE US INC | $995,356 | 0.07% | 4,509 | Common | SHARED |
| 42824C109 | HPE | HEWLETT PACKARD ENTERPRISE C | $990,452 | 0.07% | 46,391 | Common | SHARED |
| 369604301 | GE | GE AEROSPACE | $985,972 | 0.07% | 5,911 | Common | SHARED |
| 704326107 | PAYX | PAYCHEX INC | $977,802 | 0.06% | 6,973 | Common | SHARED |
| 189054109 | CLX | CLOROX CO DEL | $976,676 | 0.06% | 6,014 | Common | SHARED |
| 580135101 | MCD | MCDONALDS CORP | $975,499 | 0.06% | 3,365 | Common | SHARED |
| 963320106 | WHR | WHIRLPOOL CORP | $974,215 | 0.06% | 8,510 | Common | SHARED |
| 50107A104 | KRON1USD | KRONOS BIO INC | $953,213 | 0.06% | 1,003,382 | Common | SHARED |
| 81211K100 | SDA | SEALED AIR CORP NEW | $951,719 | 0.06% | 28,132 | Common | SHARED |
| 31428X106 | FDX | FEDEX CORP | $942,208 | 0.06% | 3,349 | Common | SHARED |
| 824348106 | SHW | SHERWIN WILLIAMS CO | $939,753 | 0.06% | 2,765 | Common | SHARED |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $909,000 | 0.06% | 900,000 | Common | SHARED |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $894,000 | 0.06% | 100,000 | Common | SHARED |
| 36828A101 | GEV | GE VERNOVA INC | $891,379 | 0.06% | 2,710 | Common | SHARED |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $878,605 | 0.06% | 1,641,945 | Common | SHARED |
| 50127T109 | KURA | KURA ONCOLOGY INC | $871,000 | 0.06% | 100,000 | Common | SHARED |
| 166764100 | CVX | CHEVRON CORP NEW | $865,854 | 0.06% | 5,978 | Common | SHARED |
| 702712100 | — | PASSAGE BIO INC | $850,650 | 0.06% | 1,500,000 | Common | SHARED |
| 345370860 | F | FORD MTR CO | $848,916 | 0.06% | 85,749 | Common | SHARED |
| 09077B104 | BCABGBP | BIOATLA INC | $812,354 | 0.05% | 1,374,076 | Common | SHARED |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $728,266 | 0.05% | 126,655 | Common | SHARED |
| 34385P108 | LAB | STANDARD BIOTOOLS INC | $713,571 | 0.05% | 407,755 | Common | SHARED |
| 556099109 | MGNX | MACROGENICS INC | $711,282 | 0.05% | 218,856 | Common | SHARED |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $627,923 | 0.04% | 850,268 | Common | SHARED |
| 74587V107 | PBYI | PUMA BIOTECHNOLOGY INC | $610,000 | 0.04% | 200,000 | Common | SHARED |
| 65343E108 | NXTCEUR | NEXTCURE INC | $539,700 | 0.04% | 700,000 | Common | SHARED |
| 28106W103 | EDIT | EDITAS MEDICINE INC | $508,000 | 0.03% | 400,000 | Common | SHARED |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $458,048 | 0.03% | 378,552 | Common | SHARED |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $378,000 | 0.03% | 100,000 | Common | SHARED |
| 89854M101 | TCRX | TSCAN THERAPEUTICS INC | $358,255 | 0.02% | 117,847 | Common | SHARED |
| 04746L104 | — | ATHIRA PHARMA INC | $352,020 | 0.02% | 600,000 | Common | SHARED |
| 69012T305 | OTLK | OUTLOOK THERAPEUTICS INC | $344,929 | 0.02% | 182,502 | Common | SHARED |
| 76152G100 | — | REVIVA PHARMACEUTCLS HLDGS I | $307,700 | 0.02% | 170,000 | Common | SHARED |
| 019818103 | — | ALLOVIR INC | $231,951 | 0.02% | 552,264 | Common | SHARED |
| N01045207 | AFMDQ | AFFIMED N V | $176,495 | 0.01% | 148,315 | Common | SHARED |
| 00534A102 | IVVD | INVIVYD INC | $146,299 | 0.01% | 330,172 | Common | SHARED |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $104,429 | 0.01% | 200,825 | Common | SHARED |
| 45254E107 | IMRX | IMMUNEERING CORP | $26,561 | 0.00% | 12,073 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.